COVID-19 患者脑与肺影像相关性:肺病严重程度能否反映神经影像急性异常
这项回顾性国际多中心研究纳入 2020年3月3日至2020年6月25日 135 例伴急性神经系统表现的住院 COVID-19 患者,比较胸部 CT 肺严重程度评分与脑影像急性异常的关系。有神经影像急性异常者平均 CT 肺严重程度评分为 9.9,高于无异常者的 5.8(P < .001);评分 >8 诊断神经影像急性异常的敏感度为 74%、特异度为 65%。作者认为 CT 肺病严重程度评分可能预测神经影像急性异常。
要点
- 伴急性神经系统症状的 COVID-19 患者中,36% 脑影像存在急性异常。
- 有神经影像急性异常者 CT 肺严重程度评分更高(9.9 vs 5.8,P < .001)。
- CT 肺严重程度评分 >8 对神经影像急性异常敏感度 74%、特异度 65%。
核心结论
- CT 肺病严重程度评分可能预测伴神经系统表现的 COVID-19 患者的神经影像急性异常,可作为患者管理中的预测工具以改善临床结局。
研究设计与样本
- 回顾性国际多中心观察性研究,纳入 2020年3月3日至2020年6月25日 伴急性神经系统表现的住院 COVID-19 患者 135 例。
- 纳入标准为确诊 SARS-CoV-2 感染、有急性神经系统表现且具备胸部 CT 与脑影像资料。
- 胸部 CT 对 5 个肺叶分别按 0–5 分评分(0 为无受累,5 为受累 >75%),肺严重程度评分为各肺叶之和,范围 0(无受累)至 25(最大受累)。
- 影像资料包括脑 CT 132 例、脑 MR 36 例、头颈部 MRA 7 例、胸部 CT 135 例。
关键影像表现/征象
- 胸部 CT 以周围性磨玻璃影伴或不伴实变为主要表现。
- 有神经影像急性异常者更常出现磨玻璃影或实变(46 例 [94%] vs 73 例 [84%],P = .01)。
- 神经影像特征包括急性缺血性梗死(28%)、颅内出血(10%,其中微出血 19%)以及伴或不伴弥散受限的白质脑病(11%)。
诊断标准与关键数值
- CT 肺严重程度评分 >8 诊断神经影像急性异常的敏感度为 74%、特异度为 65%。
- 有神经影像急性异常者 49 例(36%),其平均 CT 肺严重程度评分为 9.9,无急性异常者 86 例(64%)为 5.8(P < .001)。
- 有神经影像急性异常者更常表现为缺血性卒中(40 例 [82%] vs 11 例 [13%],P < .0001)。
临床应用与阅片要点
- 作者认为 CT 肺病严重程度评分可能预测伴神经系统表现的 COVID-19 患者的神经影像急性异常,并可作为患者管理中的预测工具以改善临床结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Our aim was to study the association between abnormal findings on chest and brain imaging in patients with coronavirus disease 2019 (COVID-19) and neurologic symptoms.
MATERIALS AND METHODS: In this retrospective, international multicenter study, we reviewed the electronic medical records and imaging of hospitalized patients with COVID-19 from March 3, 2020, to June 25, 2020. Our inclusion criteria were patients diagnosed with Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection with acute neurologic manifestations and available chest CT and brain imaging. The 5 lobes of the lungs were individually scored on a scale of 0-5 (0 corresponded to no involvement and 5 corresponded to >75% involvement). A CT lung severity score was determined as the sum of lung involvement, ranging from 0 (no involvement) to 25 (maximum involvement).
RESULTS: A total of 135 patients met the inclusion criteria with 132 brain CT, 36 brain MR imaging, 7 MRA of the head and neck, and 135 chest CT studies. Compared with 86 (64%) patients without acute abnormal findings on neuroimaging, 49 (36%) patients with these findings had a significantly higher mean CT lung severity score (9.9 versus 5.8, P < .001). These patients were more likely to present with ischemic stroke (40 [82%] versus 11 [13%], P < .0001) and were more likely to have either ground-glass opacities or consolidation (46 [94%] versus 73 [84%], P = .01) in the lungs. A threshold of the CT lung severity score of >8 was found to be 74% sensitive and 65% specific for acute abnormal findings on neuroimaging. The neuroimaging hallmarks of these patients were acute ischemic infarct (28%), intracranial hemorrhage (10%) including microhemorrhages (19%), and leukoencephalopathy with and/or without restricted diffusion (11%). The predominant CT chest findings were peripheral ground-glass opacities with or without consolidation.
CONCLUSIONS: The CT lung disease severity score may be predictive of acute abnormalities on neuroimaging in patients with COVID-19 with neurologic manifestations. This can be used as a predictive tool in patient management to improve clinical outcome.
引用
- Mahammedi A, Ramos A, Bargalló N, et al. Brain and Lung Imaging Correlation in Patients with COVID-19: Could the Severity of Lung Disease Reflect the Prevalence of Acute Abnormalities on Neuroimaging? A Global Multicenter Observational Study. AJNR Am J Neuroradiol. 2021. PMID: 33707278. doi:10.3174/ajnr.A7072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。